Literature DB >> 17426470

3' Mutation of the APC gene and family history of FAP in a patient with apparently sporadic desmoid tumors.

Laurent Benoit1, Laurence Faivre, Nicolas Cheynel, Pablo Ortega-Deballon, Olivier Facy, Marion Marty, Sophie Olschwang, Jean Fraisse, Jean Cuisenier.   

Abstract

Desmoid tumors may occur sporadically or as part of the extraintestinal manifestations of familial adenomatous polyposis. Different phenotypes have been described and some genotype-phenotype correlations have been raised, associated with different sites of germline mutations in the adenomatous polyposis coli (APC) gene. We report on a 42-year-old woman ascertained for a large desmoid tumor of the anterior chest wall with pleural involvement, which persistently recurred despite a decade of treatment including hormone therapy, chemotherapy, and surgery. Spontaneous disappearance of the tumor was later noted after 1 year without any treatment and confirmed after 4 years of regular follow-up. Repeated colonoscopies were normal in the proband and DNA sequencing showed a frameshift mutation due to a single adenosine deletion at position 5772 (codon 1924). This mutation, located in the exon 15 at the 3' end of the APC gene, leads to an unusual and late onset phenotype. The pedigree revealed other isolated or familial adenomatous polyposis-associated cases of desmoid tumors. This family report shows that a molecular analysis of the APC gene should be performed in familial desmoid tumors for accurate genetic counseling and follow-up.

Entities:  

Mesh:

Year:  2007        PMID: 17426470     DOI: 10.1097/MCG.0b013e3180325252

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  5 in total

1.  Review.

Authors:  James M Church
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-10

Review 2.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (Translated Version).

Authors:  Hideyuki Ishida; Tatsuro Yamaguchi; Kohji Tanakaya; Kiwamu Akagi; Yasuhiro Inoue; Kensuke Kumamoto; Hideki Shimodaira; Shigeki Sekine; Toshiaki Tanaka; Akiko Chino; Naohiro Tomita; Takeshi Nakajima; Hirotoshi Hasegawa; Takao Hinoi; Akira Hirasawa; Yasuyuki Miyakura; Yoshie Murakami; Kei Muro; Yoichi Ajioka; Yojiro Hashiguchi; Yoshinori Ito; Yutaka Saito; Tetsuya Hamaguchi; Megumi Ishiguro; Soichiro Ishihara; Yukihide Kanemitsu; Hiroshi Kawano; Yusuke Kinugasa; Norihiro Kokudo; Keiko Murofushi; Takako Nakajima; Shiro Oka; Yoshiharu Sakai; Akihiko Tsuji; Keisuke Uehara; Hideki Ueno; Kentaro Yamazaki; Masahiro Yoshida; Takayuki Yoshino; Narikazu Boku; Takahiro Fujimori; Michio Itabashi; Nobuo Koinuma; Takayuki Morita; Genichi Nishimura; Yuh Sakata; Yasuhiro Shimada; Keiichi Takahashi; Shinji Tanaka; Osamu Tsuruta; Toshiharu Yamaguchi; Kenichi Sugihara; Toshiaki Watanabe
Journal:  J Anus Rectum Colon       Date:  2018-05-25

3.  Surgical prophylaxis in familial adenomatous polyposis: do pre-existing desmoids outside the abdominal cavity matter?

Authors:  Ashish Sinha; Daniel C Gibbons; Robin K Phillips; Sue Clark
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

4.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer.

Authors:  Naohiro Tomita; Hideyuki Ishida; Kohji Tanakaya; Tatsuro Yamaguchi; Kensuke Kumamoto; Toshiaki Tanaka; Takao Hinoi; Yasuyuki Miyakura; Hirotoshi Hasegawa; Tetsuji Takayama; Hideki Ishikawa; Takeshi Nakajima; Akiko Chino; Hideki Shimodaira; Akira Hirasawa; Yoshiko Nakayama; Shigeki Sekine; Kazuo Tamura; Kiwamu Akagi; Yuko Kawasaki; Hirotoshi Kobayashi; Masami Arai; Michio Itabashi; Yojiro Hashiguchi; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2021-06-29       Impact factor: 3.402

5.  APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis.

Authors:  Astrid Tenden Stormorken; Thomas Berg; Ole-Jacob Norum; Toto Hølmebakk; Kristin Aaberg; Sonja E Steigen; Eli Marie Grindedal
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.